In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
Dear All, A study published in a major journal again identified lack of development of systems for pharmacovigilance as barriers to access to bedaquiline. The authors emphasized that despite limitations increased access to bedaquiline is possible with the presence of clinical review committee; easy access to ECG monitoring; and presence ... read more
To share a new publication (attached) Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study Lancet Respir Med 2017 Dheda et al Background: The emergence of programmatically incurable tuberculosis threatens to destabilise control efforts. The aim of ... read more
Thank you, Masoud, for sharing this important study. This was a very nice paper, and good to see the impact of using Xpert in active case finding not only on increasing the proportion of patients starting treatment, but also in reducing the time to treatment initiation from 4 days to ... read more
Dear all. Thanks for your replys. For the first tuberculosis, I don´t know her adherence, but for the second one (this that has finished in failure) it has been good. she has just missed 5 doses in intensive phase and they prolonged until 3 months this phase. Even without DOT, ... read more
International Panel Physicians AssociationWork Locations
Palm Beach State CollegeWork Locations